Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Science Advances|December 14, 2020
Exploiting the diphtheria toxin internalization receptor enhances delivery of proteins to lysosomes for enzyme replacement therapySeiji N Sugiman-Marangos, Greg L Beilhartz, Xiaochu Zhao, et al.Connective Tissue Research|June 7, 2006
Comparison of fetal and adult marrow stromal cells in osteogenesis with and without glucocorticoidsPi-Ling Chang, Harry C Blair, Xiaochu Zhao, et al.The Journal of Biological Chemistry|December 5, 2020
An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in miceSilvia Nitschke, Erin E Chown, Xiaochu Zhao, et al.Annals of Neurology|August 6, 2013
Inhibiting glycogen synthesis prevents Lafora disease in a mouse modelBartholomew A Pederson, Julie Turnbull, Jonathan R Epp, et al.Plos Genetics|May 10, 2011
PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora diseaseJulie Turnbull, Anna A DePaoli-Roach, Xiaochu Zhao, et al.Annals of Neurology|November 16, 2010
Glycogen hyperphosphorylation underlies lafora body formationJulie Turnbull, Peixiang Wang, Jean-Marie Girard, et al.Cell Metabolism|May 14, 2013
Hyperphosphorylation of glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora diseaseFelix Nitschke, Peixiang Wang, Peter Schmieder, et al.Proceedings of the National Academy of Sciences of the United States of America|November 28, 2007
Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivoVincent S Tagliabracci, Julie Turnbull, Wei Wang, et al.Nature Microbiology|February 12, 2019
Adeno-associated virus 2 bound to its cellular receptor AAVRRan Zhang, Lin Cao, Mengtian Cui, et al.EMBO Molecular Medicine|May 25, 2017
Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora diseaseFelix Nitschke, Mitchell A Sullivan, Peixiang Wang, et al.Pageof 3